09:36 AM EDT, 03/19/2025 (MT Newswires) -- Kamada ( KMDA ) said Wednesday it opened a new plasma collection center in San Antonio, Texas, with an expected annual collection capacity of about 50,000 liters.

The plasma-derived protein therapeutics manufacturer said the new facility will collect normal source plasma for third-party sales and specialty plasma, including Anti-Rabies and Anti-D, for internal use.

The company said it expects sales of normal source plasma from the site to generate $8 million to $10 million annually at full capacity.

Kamada ( KMDA ) said it plans to seek regulatory approvals for the new site from the US Food and Drug Administration and the European Medicines Agency in H2.

Price: 6.69, Change: +0.03, Percent Change: +0.45